NASDAQ:KZR
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up
Kezar Life Sciences revealed a major regulatory setback for its lead drug and immediately pivoted to consider strategic alternatives. In an October 16 press release, the South San Francisco company announced it failed to…
Company hubNASDAQ:KZR
Kezar Life Sciences (KZR) Stock News & Analysis
Follow the latest Kezar Life Sciences (KZR) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
All coverage